According to Captor Therapeutics's latest financial reports the company's current EPS (TTM) is S-$2.84. In 2023 the company made an earnings per share (EPS) of S-$4.98 a decrease over its 2022 EPS that were of S-$2.54.
Year | EPS | Change |
---|---|---|
2025 (TTM) | S-$3.00 | |
2023 | S-$4.98 | 96.01% |
2022 | S-$2.54 | 1.44% |
2021 | S-$2.50 | 85.38% |
2020 | S-$1.35 | 56.29% |
2019 | S-$0.86 | 85.83% |
2018 | S-$0.46 | 2177.9% |
2017 | S-$0.02041 |